Hawk70 yes after 6 months they would have :
1. cleared all pre clinical success for TB and stroke
2. drug is safe in humans
3. phase 1 complete for TB and Stroke
4. recieved additional 5-10 milion in non dilutive funding
5. submitted and waiting on the fast track of phase 2 with FDA
6. Further developed its Joint venture with the US defence force
But worth 1.5 cents a 2 million market cap. Donkeys can downramp to accumulate better than you. Like AGN which is only doing phase 1 and 2 for stroke which is now a 120 million market cap and running towards a billion dollar market cap, keep posting
Ann: NYR Signs Strategic Partnership with US Brain Injury Company, page-43
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $23.05M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $90.17K | 823.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 760879 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 57758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |